DPP-4抑制剂对2型糖尿病依从性的影响
摘要
目前，2型糖尿病的发病率在世界范围内增长迅速，全世界约有2．46亿人患有2型糖尿病．我国2型糖尿病的总人数位居世界第一。然而对于血糖的良好持久控制并不乐观．尚存在诸多的困难。
出处
《药品评价》
CAS
2011年第21期42-45,共4页
Drug Evaluation
参考文献23
-
1Aschner E Kipnes MS, Lunceford JK, et al. Effect of the dipeptidyl peptidase-4 inhibitor sitagliptin as monotherapy on glycemic control in patients with type 2 diabetes[J]. Diabetes Care, 2006, 29(12): 2632-2637.
-
2Raz I, Hanefeld M, Xu L, et al. Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin as monotherapy in patients with type 2 diabetes[J]. Diahetologia, 2006, 49: 2564-2571.
-
3Ahren B, Landin-Olsson M, Jansson PA, et al. Inhibition of dipeptidyl peptidase-4 reduces glycemia, sustains insulin levels, and reduces glucagons levels in type 2 diabetes[J]. J Clin Endocrinol Metab, 2004, 89: 2078-2084.
-
4Dejager S, Razac S, Foley JE, et al. Vildagliptin in drug-naive patients with type 2 diabetes: a 24-week, doubleblind, randomized, placebo-controlled, multipledose study[J]. Horm Metab Res, 2007, 39(3): 218 223.
-
5Pratley RE, Jauffret-Kramel S, Galbreath E, et al. Twelve-week monotherapy with DPP-4 inhibitor vildagliptin improves glycemic control in subjects with type 2 diabetes[J]. Horm Metab Res, 2006, 38: 423-428.
-
6Pi-Sunyer FX, Schweitzer A, Mills D, et al. Efficacy and tolerability of vildagliptin monotherapy in drug-naive patients with type 2 diabetes[J]. Diab Res Clin Pract, 2007, 76: 132-138.
-
7Saxagliptin (Onglyza) for type 2 diabetes[J]. Med Lett Drugs Ther, 2009, 51: 85-86.
-
8Rosenstock J, Aguilar Salinas C, Klein E, et al. CV181-011 Study Investigators. Effect of saxagliptin monotherapy in treatment-naive patients with type 2 diabetes[J]. Curr Med Res Opin, 2009, 25:2401-2411.
-
9Ahren B, Gomis R, Standl E, et al. Twelveand 52-week etficacy of the dipeptidyl peptidase IV irdaibitor LAF 237 in metformin treated patients with type 2 diabetes[J]. Diabetes Care, 2004, 27: 2874-2880.
-
10Bosi E, Camisaca RP, Collober C, et al. Effects ofvildagliptin on glucose control over 24 weeks in patients with 'type 2 diabetes inadequately controlled with metformin[J]. Diabetes Care, 2007, 30: 890-895.
-
1周立春.糖尿病患者肢体发麻警惕周围神经病变[J].医药与保健,2012(12):37-37.
-
2邱济海,杨亦德,侯伟,谢红东.314例肺结核患者的流行病学分析[J].浙江中西医结合杂志,2011,21(12):899-900.
-
3吴爱荣,徐以勒,刘松青,潘文俊.涂阳肺结核153例的影响治愈因素分析[J].中国乡村医药,2009,16(10):15-15.
-
4殷华美.扬中市2005～2007年初诊肺结核病人流行病学特征及分析[J].中国卫生检验杂志,2008,18(12):2823-2824. 被引量：4
-
5刘富强,郭绶衡,胡世雄,李原浩.湖南省1999-2003年人间狂犬病流行情况分析[J].中华流行病学杂志,2004,25(12):1088-1088. 被引量：9
-
6徐艳声,梁军,李平,李婕,李育芬,赵山平,楚承霞,杨颖.昆明市吸毒人员HCV感染及相关因素分析[J].皮肤病与性病,2012,34(1):49-51. 被引量：4
-
7朱瑞芳.耐药结核生命的又一次威胁[J].家庭护士,2006(12S):18-19.
-
8陈淑琼,曹鸿远.结核病的实验室诊断现状及进展简述[J].医学理论与实践,2014,27(16):2135-2136. 被引量：8
-
9党宽怀,胡金贵,候宝兰,王政.80例肝炎后肝硬化患者心电图改变及影响因素[J].武警后勤学院学报（医学版）,1998,19(2):109-110.
-
10刘媛,高军.“院内感染”埋下疾病传播的巨大隐患[J].首都医药,2006,13(3):17-23.
